Added to YB: 2024-09-17
Pitch date: 2024-09-10
CRL [bullish]
Charles River Laboratories International, Inc.
+53.39%
current return
Author Info
No bio for this author
Company Info
Charles River Laboratories International, Inc. provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally.
Market Cap
$13.4B
Pitch Price
$189.06
Price Target
N/A
Dividend
N/A
EV/EBITDA
16.99
P/E
-57.37
EV/Sales
4.07
Sector
Life Sciences Tools and Services
Category
turnaround
Brown Capital Management Mid Company Fund Portfolio Holding: Charles River Laboratories International, Inc.
CRL: Leading pre-clinical CRO involved in 80%+ FDA-approved drugs. Revenue shrinking due to weak funding for biotech clients (40% of base) amid high rates. Worst capital-raising environment in 5+ years. Long-term outlook positive: key partner, market leader in several divisions, poised to benefit when drug innovation rebounds.
Read full article (1 min)